Connor Dowling is a Executive Director, The Daniel Offit Fund to Fight Glioblastoma at Offit Capital. He possess expertise in new business development, business strategy, data analysis, project management, market research and 17 more skills. Colleagues describe him as "Connor was instrumental in helping us get Destroke off the ground. At the BioVenture eLab, he was a strong supporter of our company, constantly introducing us to mentors, potential investors, and inviting us to pitch at Weill Cornell symposia. He introduced us to many of our current collaborators and even 2 years later, still advocates for us throughout the Weill Cornell Medicine and NYC digital health communities. Great advocate and person to work with! Highly recommended!", "Connor and the BioVenture eLab have been and continue to be exceptional in their contributions to the NYC biotech ecosystem and entrepreneurs in the Tri-Institutions and across the city. They have built a hub of entrepreneurship in the upper east side that has resulted in the founding of multiple companies that are developing crucial new technologies to improve the lives of patients.", and "Connor and the BioVenture eLab have been extremely helpful to Goldilocks in terms of thinking through potential investors (and making introductions when appropriate) as well as overseeing our relationship with the Weill Cornell Executive MBA Capstone internship program. He has been terrific to work with, and I highly recommend."